|
|
||||||||
Technical Briefs |
1 Department of Pathology and Immunology, Division of Laboratory Medicine, Washington University School of Medicine, 660 South Euclid Ave., Box 8118, St. Louis, MO 63110
aauthor for correspondence: fax 314-362-1461, e-mail gronowski@pathology.wustl.edu
| The first 20% of the full text of this article appears below. |
Methods to quantify human chorionic gonadotropin (hCG) in serum are well established (1), but automated quantitative urine assays are not readily available. When the validity of point-of-care qualitative urine hCG results are called into question, a rapid quantitative method for urine hCG could be useful. In the present study, we have validated the Abbott AxSYM Total ß-hCG (Abbott Laboratories) assay (approved for serum use only) for use in the quantitative determination of urinary concentrations of total ß-hCG.
Recovery studies were performed by adding hCG (US Pharmacopeia) to urine from premenopausal, nonpregnant females. Recovery studies were carried out in quadruplicate in two separate experiments. Recovery was 99112% at concentrations of 26725 IU/L (Table 1
). Urine protein at concentrations up to 7.4 g/L had no effect on recovery (not shown).
|
Intra- and interassay imprecision was
The following articles in journals at HighWire Press have cited this article:
![]() |
A. M. Halldorsdottir, M. O. Carayannopoulos, M. Scrivner, and A. M. Gronowski Method Evaluation for Total {beta}-Human Chorionic Gonadotropin Using Urine and the ADVIA Centaur Clin. Chem., August 1, 2003; 49(8): 1421 - 1422. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |